Statements of Cash Flows - USD ($)	11 Months Ended	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2022
Cash Flows From Operating Activities:
Net income	$ 11,639,507	$ 13,805,233
Adjustments to reconcile net income (loss) to net cash used in operating activities:
Investment income earned on investments held in the Trust Account	(16,116)	(3,376,559)
Gain on change in fair value of derivative liabilities	(17,270,000)	(12,591,000)
Excess fair value of private warrants over proceeds	4,080,000	0
Transaction costs allocable to warrant liability	926,044	0
Changes in operating assets and liabilities:
Prepaid expenses	(458,133)	78,869
Other assets	(370,931)	370,931
Other deferred expenses	0	12,815
Accounts payable and accrued expenses	341,555	150,323
Net Cash Used In Operating Activities	(1,128,074)	(1,549,388)
Cash Flows From Investing Activities:
Cash deposited into Trust Account	(234,600,000)	0
Taxes paid from trust	0	619,137
Net Cash (Used In) Provided by Investing Activities	(234,600,000)	619,137
Cash Flows From Financing Activities:
Proceeds from issuance of Class A ordinary shares	230,000,000	0
Proceeds from sale of Private Placement Warrants	12,000,000	0
Payment of underwriter discounts and commissions	(4,600,000)	0
Proceeds from loan payable - sponsor	0	175,000
Proceeds from promissory note	250,000	0
Repayment of promissory note	(250,000)	0
Proceeds from issuance of Class B common stock to sponsor	25,000	0
Proceeds from related party advances	20,000	0
Repayment of related party advances	(32,111)	(3,661)
Payments of offering costs	(705,589)	(8,082)
Net Cash Provided By Financing Activities	236,707,300	163,257
Net change in cash	979,226	(766,994)
Cash at beginning of period	0	979,226
Cash at end of period	979,226	212,232
Non-cash financing activities:
Offering costs included in accrued offering costs	17,388	0
Expenses paid by related party	15,984	0
initial classification value of common stock subject to possible redemption	202,355,564	0
Remeasurement of Class A common stock subject to possible redemption	32,244,436	1,785,597
Fair value of warrants issued with stock	15,180,000	0
Deferred underwriting agreement	$ 8,050,000	$ 0